← Leaderboards
Hiroko Yano
Brigham And Women'S Hospital
$3,533,714
Attributed
$3,962,276
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $595.2K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,962,276 · 5
By mechanism
R01$2,034,675 · 1
R21$1,276,500 · 3
K01$651,101 · 1
Top collaborators
- Sheng-Kwei Song2 shared
- Guoyan Zhao2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Robert O Wright$90,369,790
- Chinweike Ukomadu$2,314,952
- James W Mier$3,282,868
- Dawn L Demeo$10,537,091
- Nathan J McDannold$12,807,496
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMolecularPolyglutamineNeuronsNeurodegenerative DisordersHuntington DiseaseBrainPathogenesisDisease ModelEpigenetic ProcessMutantGenetic TranscriptionNerve DegenerationCellsFunctional DisorderNeuron LossPlayAtrophicDisease ProgressionMediatingCorpus Striatum StructureGene TargetingMouse ModelHuntington Gene
Grant awards (17)
Therapeutic targeting of DNA methyltransferases in Huntington's disease$194,375
R21 · FY2025 · NS · contact PI
Therapeutic targeting of DNA methyltransferases in Huntington's disease$233,250
R21 · FY2024 · NS · contact PI
Role of DNA methyltransferases in Huntington's disease$372,869
R01 · FY2023 · NS · contact PI
Role of DNA methyltransferases in Huntington's disease$408,505
R01 · FY2022 · NS · contact PI
Role of DNA methyltransferases in Huntington's disease$427,153
R01 · FY2021 · NS · contact PI
Role of DNA methyltransferases in Huntington's disease$427,153
R01 · FY2020 · NS · contact PI
Role of DNA methyltransferases in Huntington's disease$398,995
R01 · FY2019 · NS · contact PI
ESTABLISHING DIFFUSION BASIS SPECTRUM IMAGING AS A NEW BIOMARKER FOR HUNTINGTON'S DISEASE PROGRESSION$196,250
R21 · FY2019 · NS · contact PI
ESTABLISHING DIFFUSION BASIS SPECTRUM IMAGING AS A NEW BIOMARKER FOR HUNTINGTON'S DISEASE PROGRESSION$233,250
R21 · FY2018 · NS · contact PI
EPIGENETIC AND MRNA PROFILING OF STRIATOPALLIDAL NEURONS IN HUNTINGTON'S DISEASE$228,750
R21 · FY2017 · NS · contact PI
EPIGENETIC AND MRNA PROFILING OF STRIATOPALLIDAL NEURONS IN HUNTINGTON'S DISEASE$190,625
R21 · FY2016 · NS · contact PI
Polycomb-mediated epigenetic mechanisms in neurodegeneration and aging brain$126,644
K01 · FY2013 · AG · contact PI
Polycomb-mediated epigenetic mechanisms in neurodegeneration and aging brain$129,176
K01 · FY2012 · AG · contact PI
Polycomb-mediated epigenetic mechanisms in neurodegeneration and aging brain$1
K01 · FY2012 · AG · contact PI
Polycomb-mediated epigenetic mechanisms in neurodegeneration and aging brain$131,760
K01 · FY2011 · AG · contact PI
Polycomb-mediated epigenetic mechanisms in neurodegeneration and aging brain$131,760
K01 · FY2010 · AG · contact PI
Polycomb-mediated epigenetic mechanisms in neurodegeneration and aging brain$131,760
K01 · FY2009 · AG · contact PI